How aging increases the risk of Alzheimer's disease is not clear. We show that normal 19 neuronal aging increases the intracellular production of β-amyloid, due to an upregulation of the 20 amyloid precursor protein endocytosis. Importantly, increased Aβ production contributes to the 21 aging-dependent synapse loss. 22 23 24 25 3 Abstract 26 27
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senescence (Aksenova et al., 1999; Goslin and Banker, 1989; Martin et al., 2011; Youmans et al., 138 2012; Papa et al., 1995; Trovò et al., 2013) . We observed that, primary neurons cultured for 28 DIV 139 had levels of MAP2 similar to 21 DIV neurons ( Fig. 1A, B ) and did not present gross morphological 140 changes such as axonal bead-like degeneration or dendritic shrinkage (Fig.1C-F) . Importantly, 28 DIV 141 neurons showed canonical signs of cellular aging, such as the formation of auto-fluorescent aging 142 granules, or lipofuscin ( Fig. S1A -E) as previously described (Gray and Woulfe, 2005) . Importantly, 143 the number of auto-fluorescent granules within lysosome associated membrane protein 1 (LAMP1)-144 positive lysosomes was significantly higher in the cell bodies of aged neurons (28 DIV) than in mature 145 neurons (21 DIV), consistent with the aging-dependent accumulation of lysosomal lipofuscin ( Fig.  146 1G-K). Thus, we established a model of cellular aging of post-mitotic neurons that, after reaching 147 maturation, undergo cellular aging, without neurodegeneration. 148
Previously, we demonstrated that intracellular Aβ42 progressively accumulates in older 149 primary cortical neurons due to overexpression of mutant hAPP (Swe) (Takahashi et al., 2004) . Now, 150 to determine if neuronal aging can induce quantitative changes in intracellular endogenous Aβ42, 151 we used a novel and highly sensitive semiquantitative immunofluorescence assay using an anti-152
Aβ42 C-terminal specific antibody (12F4) (Ubelmann et al., 2017b) . By analyzing the accumulation 153 of Aβ42 in neurites and cell bodies separately we discovered a significant increase in Aβ42 154 accumulation (56%) in aged neurites compared to mature neurites ( Fig. 1M, N To assess if neuronal aging increased Aβ42 by potentiating the processing of APP we 163 analyzed the levels of APP C-terminal fragments (APP CTFs) by western blot using an anti-APP C-164 terminal (APPY188) antibody. We found that the levels of APP CTFs increased in aged neurons 165 compared with those in mature neurons ( Fig. 2A, B ). This increase in APP CTFs together with the 166 increase in intracellular Aβ42 indicate that endogenous APP is being more processed in aged 167 neurons. Of note, we found that neuronal maturation did not significantly affect APP processing, 168 since the levels of APP CTFs in mature neurons (21 DIV) were similar to those in immature neurons 169 (14DIV) ( Fig. 2A, B) . Interestingly, the levels of full-length APP were not significantly altered between 170 mature and aged neurons (Fig. 2C, D) , discarding a major impact of neuronal aging in culture on APP 171 expression or degradation. We observed an increase in the levels of APP when comparing mature 172 to immature neurons, likely due to APP being increasingly expressed with neuronal maturation and 173 synaptogenesis ( Since Aβ accumulation and APP processing occur mostly in neurites, close to distal synapses 182 (Takahashi et al., 2004; Das et al., 2016) we analyzed the impact of neuronal aging on the 183 distribution of APP between the cell body and neurites. We applied our semiquantitative 184 immunofluorescence assay to measure the enrichment of APP in neurites vs cell bodies of aged and 185 mature neurons. We found a major increase in APP intensity in aged neurites (52%) compared to 186 mature neurites ( Fig. 3A-C) . In contrast, no significant difference in APP intensity was observed with 187 12 ( Fig. 6B ). Importantly, we did not detect alterations in the levels of full-length APP in vivo (Fig. 6C ). 287
Again, as in in vitro aged neurons, we found that the levels of EEA1 increased in aged mice when 288 compared to young mice ( Fig. 6A, D) . 289
Together these results indicate that, during aging, there is an up-regulation of endocytosis 290 which correlates with increased processing of APP in the brain, recapitulating fundamental 291 mechanistic findings in in vitro neurons aged. 292 293 Aging-dependent synapse loss is in part due to Aβ production 294 295 Synapse dysfunction, more than neuronal death or dendritic shrinkage, has been observed 296 in the aging brain. Synapse dysfunction is thought to account for the cognitive decline that the 297 elderly develops, and it may precede AD. To determine if the increased Aβ production by aged 298 neurons had a synaptic impact, we first assessed synapse decline in our neuronal model of aging, as 299 previously reported both in vitro and in vivo (Nwabuisi-Heath et al., 2012; Petralia et al., 2014) . As a 300 proxy for a synapse, we imaged and quantified, the juxtaposition of the pre-synaptic marker vGlut1, 301 a glutamate transporter, and of the post-synaptic marker PSD-95, a post-synaptic density scaffold 302 that anchors glutamate receptors at synapses. Consistent with previous studies, we found that the 303 density of synapses decreased significantly by 54% in aged neurons ( Fig. 7A , 7B, 7D, 7E and 7M) 304 (Papa et al., 1995; Nwabuisi-Heath et al., 2012) . Given that the density of synapses declines in aged 305 neurons that also show increased production of Aβ (see Fig. 1 and 2), we hypothesized that we could 306 rescue the age-dependent reduction in synapse number by inhibiting γ-secretase-dependent Aβ 307 production for 24 h with γ-secretase inhibitor (DAPT), which we previously showed to efficiently 308 block APP processing . Importantly, when we treated aged neurons with DAPT, 309 the number of synapses increased significantly by 42%, partially rescuing the synapses lost due to 310 neuronal aging ( Fig. 7C, 7F , 7M). This result implicates Aβ42 production as a causal mechanism of 311 synapse loss in aged neurons. Since the rescue was not complete, it indicates that other mechanisms 312 of aging also contribute to synapse decline. 313
To better understand why synapses were lost, we analyzed the density, size and intensity of 314 each PSD-95 and vGlut1 puncta. We found that, for PSD-95, all three parameters were significantly 315 reduced in aged neurons ( Fig. 7G , 7H, 7N-7P). Surprisingly, only the intensity of PSD-95 puncta 316 improved upon DAPT treatment ( Fig. 7I, 7P ). Further, vGlut1 density and intensity were slightly but 317 significantly reduced in aged neurons ( Fig. 7J , 7K, 7N, 7P). Interestingly, only the density of vGlut1 318 13 increased significantly upon DAPT treatment ( Fig. 7L, 7N ), indicating that Aβ production may impact 319 both the PSD-95 positive post-synaptic compartment and the vGlut1 positive pre-synaptic 320 compartment. Of note, the total levels of post-synaptic markers, PSD-95 and GluA2, the AMPA 321 glutamate receptor subunit, as well as vGlut1 were not significantly altered in aged neurons ( Fig.  322 7Q, R). Our data support that the defects observed refer to synapse loss and not to major neuronal 323 degeneration (see Fig. 1 ). 324
Overall, from our data, we conclude that Aβ production may account at least in part for the 325 detrimental effect of aging on synapses. The accumulation of Aβ42 results from the imbalance between production and clearance. 331
Aβ accumulation in the aging brain was until now explained by a decline in Aβ degradation with 332 aging (Saido and Leissring, 2012) ; however, whether Aβ production increases with aging cannot be 333 ruled out. Here, we observed that endogenous APP is increasingly processed with neuronal aging to 334 generate Aβ. Importantly, we discovered that aged neurons endocytose more APP, facilitating APP 335 processing required for Aβ generation in neurites. Furthermore, we also provide evidence that the 336 normal age-related Aβ production is in part responsible for the loss of synapses by aged neurons, 337 and thus may be initiating a pathological mechanism during aging which could trigger Alzheimer's 338 disease. Therefore, we propose that Aβ production is involved in neuronal aging. We found that the intracellular accumulation of Aβ42 together with the augmented levels of APP 358
CTFs both in in vitro aged neurons and in in vivo aged brain ( Fig. 2 and Fig. 6 ) strongly indicate that 359 APP processing originating Aβ42 is increased in aged neurons. 360
Why does APP processing increase with aging? 361
Aging impact on APP processing is likely independent of alterations in the cellular levels of 362 APP, which we found not to be significantly altered both in vitro and in vivo, supporting similar 363 observations during normal brain aging (Flood et al., 1997; Gegelashvili et al., 1994) . However, these 364 results are not consensual since while some report APP increased with aging in vitro and in vivo 365 (Sinha et al., 2016; Guix et al., 2012) other report APP decreased with aging in vivo (Kern et al., 2006) . 366
We hypothesize that these differences may occur due to the different brain regions analyzed or to 367 the different conditions of primary neurons culture. Overall, one may conclude that the differences 368 in APP levels, if exist, are not major and thus are not sufficient to account for the increase in APP 369 processing with aging. BACE1 activity is not due to an increase in the level of BACE1 in the aged brain (Fukumoto et al., 379 2004 ), which we also did not see altered in our aged neurons. Instead, an increase in the access of 380 APP to BACE1, due to altered APP trafficking, could underlie the increase in processing. 381
Indeed we discovered that APP endocytosis is significantly increased in aged neurons, which 382 could explain the increase in APP processing, since endocytosis has been shown to be required for 383 APP encounter with its secretases and for Aβ production ( Contrary to the generalized increase in endocytosis with aging is the fact that we found 402 transferrin endocytosis reduced in aging neurons, which could be due to a reduced rate of 403 transferrin exit from endocytic clathrin-coated pits in aged neurons (Blanpied et al., 2003) . 404
Alternatively, the reduced transferrin endocytosis might be due to a specific reduction in the 405 expression of transferrin receptor in the aged hippocampus (Lu et al., 2017) . Overall, our findings indicate that early endosome enlargement results from increased 429 endocytic uptake. 430
Synapse dysfunction in aging and Alzheimer's 431
Although the accumulation of Aβ is concomitant with synapse dysfunction in the aging brain, 432 causality has not been established. Here, we found that inhibition of Aβ production increases the 433 number of synapses in aged neurons. However, the rescue was only partial, indicating that other 434 mechanisms could contribute to synapse loss during aging (Yankner et al., 2008) . Overall, our findings indicate that the up-regulation of APP endocytosis is a cell autonomous 444 mechanism by which neurons contribute to brain aging. Our next step will be to device new 445 technology that allow for measuring endocytosis in neurons in vivo. It will be interesting to 446 determine the impact of aging on other brain cells, such as astrocytes and microglia. We plan in our 447 future studies to incorporate several brain cell-types in more complex culture models to study brain 448 aging mechanisms. 449
Our work highlights the involvement of APP endocytosis as a key link between aging and AD. 450
The increased processing of APP and Aβ42 accumulation points to an impairment in endocytic 451 trafficking towards early endosomes as neurons get older. Also, we found that the detrimental 452 effect of aging on synapses account, at least in part, to Aβ production. Hence, the identification of 453 the mechanisms underlying aging-synaptic decline is urgent to reverse synaptic dysfunction and 454 thus prevent cognitive decline in the face of aging, delaying AD. The following primary antibodies were used: Anti-Ankyrin-G pAb (P-20, Santa Cruz, cat sc-475 31778, 1:100); anti-APP mAb (22C11, Millipore, cat MAB348, 1:100); anti-APP (Y188, GeneTex, cat 476 GTX61201, 1:200; 1:1,000); anti-Aβ42 mAb (12F4, Millipore, cat 05-831-l, 1:50); anti-BACE1 pAb 477 (Thermo Scientific, cat PA1-757, 1:850); anti-EEA1 pAb (N-19, Abcam, cat sc-6415, 1:50); anti-MAP2 478 mAb (Sigma, M4403, 1:500); anti-nicastrin pAb (Thermo Scientific, cat PA1-758, 1:500); anti-tubulin 479 mAb (Tu-20, Millipore, cat MAB1637, 1:10,000); anti-LAMP1 (CD107a, BD Pharmingen, cat 553792; Healthcare). Images of immunoblots were captured using ChemiDoc (Bio-Rad) within the linear 510 range and quantified by densitometry using the "Analyse gels" function in ImageJ. 511 512
Trafficking assays 513
For bulk endocytosis of biotinylated APP (Fig. 4 ) biotinylation of surface APP was performed 514 as previously described (Almeida et al., 2006) . Briefly, neurons at 21 DIV and 28 DIV were incubated 515 on ice with 0.5 mg/ml Sulfo-NHS-LC-Biotin (Pierce) in PBS for 30 min. Free biotin was quenched with 516 ice-cold 0.5 % BSA in PBS. Biotinylated proteins were chased for 10 min and 30 min at 37 ºC to allow 517 for detecting endocytosis. For detection of surface biotin-APP, cells were rinsed, and lysates 518 prepared in RIPA buffer. For detection of endocytosed biotin-APP, surface biotin was stripped by 519 treating cells with GSH (50 mM) in stripping buffer (75 mM NaCl, 10 mM EGTA, 1% BSA, pH 7.8 -8) 520 20 for 15 min on ice before lysates were prepared. Biotinylated proteins were immunoprecipitated 521 with NeutrAvidin agarose beads (Pierce) overnight at 4°C and, after washing, separated by SDS-522 PAGE. Quantitative immunoblotting was performed using anti-APP (Y188) antibody in biotinylated 523 proteins and total proteins. 524
For APP endocytosis (Fig. 4) , a 10 min pulse with a monoclonal mouse antibody against the 525 extracellular N-terminus of surface APP (22C11) was performed as previously described (Ubelmann 526 et al., 2017a) . After a 10 min pulse at 37ºC in complete medium with 10 mM HEPES, cells were fixed 527 and immunolabelled with a secondary antibody anti-mouse and mounted or co-labelled for Rab5 528 (Fig. S2) . 529
For transferrin endocytosis (Fig. 5) , a 10 min pulse with transferrin was performed as 530 previously described (Almeida 2006) . Briefly, neurons were incubated with 10 µg/ml of transferrin 531 labelled with Alexa647 (A647-Tf; LifeTechnologies, cat. T23366) in complete medium with 10 mM 532 HEPES for 10 min (pulse) at 37ºC. After, cells were fixed, permeabilized and labelled with Phalloidin 533 to probe F-actin, washed and mounted. 534 535
Quantitative analyses 536
Image analyses were carried out using ImageJ (imagej.nih.gov/ij), Fiji (fiji.sc) or ICY 537 (icy.bioimageanalysis.org). 538
For the quantification of the number of auto-fluorescent granules positive for LAMP1 (Fig.  539 1K) and auto-fluorescent granules (Fig. S1 ) per area of dendrite (density), dendritic segments were 540 outlined with ICY, LAMP1 and auto-fluorescent granules were segmented and counted 541 automatically using the ICY "Spot detector" plugin, and the number of colocalizations (lysosomal 542 lipofuscin) was obtained using the ICY "colocalization studio" plugin. 543
For the subcellular quantification of intracellular Aβ42 levels ( Fig. 1R ) and of APP levels (Fig.  544 3C) the mean fluorescence of Aβ42/APP in the cell body and in neurites was measured using ImageJ. 545
The cell body and a region of background was outlined using "polygon selection". For selecting a 546 region of neurites, a square (500 x 500) was centered on each primary dendrite. The mean 547 fluorescence of Aβ42/APP in each region was quantified with "Measure" function. The mean 548 fluorescence per region was calculated as percentage of the indicated control, upon background 549 fluorescence subtraction. 550
For the quantification of APP levels in axons vs dendrites (Fig. 3J, K) , two subcellular regions 551 of interest (ROI), axon (AnkG positive) and dendrite (AnkG negative) were outlined using ImageJ 552 "polygon selection". The mean fluorescence of APP in each ROI was quantified as above. For the 553 quantification of APP polarization, APP mean fluorescence in the axon ROI was divided by the APP 554 mean fluorescence in the dendrite ROI (APP axon/dendrite ratio). APP mean fluorescence in axons 555 vs dendrites was calculated as above. 556
For the quantification of APP colocalization with EEA1 density per area (Fig. 3P) , of 557 endocytosed APP (22C11) colocalization with Rab5 percentage (Fig.S2) , or PSD-95 colocalization 558 with vGlut1 (synapse) density per length of neurite (Fig. 7M) , the number of colocalizing objects was 559 obtained using ICY "Colocalizer" protocol. The area or length (Feret's diameter) of the neurite ROI 560 was obtained using ICY ROI export. 561
For the quantification of puncta density per area, intensity and size of endocytosed APP 562 (22C11), EEA1, PSD-95, vGlut ( Fig. 4M, 4N , 4O, 5G, 5H, 5I, 7N, 7O, 7P) and for density of endocytosed 563 transferrin (Fig. 5Q ), the ICY "spot detector" was used. We thank for the gift of antibodies to Dr. Stephanie Miserey-Lenkei (Institute Curie). We 586 thank Dr. F. Ubelmann, Dr. R. M. Oliveira and L. Salavessa for helpful discussions. We thank M. 587
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